AstraZeneca and Daiichi Sankyo’s ENHERTU showed objective response rates of 49% and 56% with 5.4mg/kg and 6.4mg/kg doses respectively in primary analysis
ENHERTU provided a median.
Daiichi Sankyo and AstraZeneca’s ENHERTU showed objective response rates of 49% and 56% with 5.4 mg/kg and 6.4 mg/kg doses, respectively, in primary analysis
ENHERTU provided a median.
Teva will share 16 data presentations across its neuroscience portfolio including AUSTEDO, once-daily AUSTEDO XR, UZEDY, TV-44749 and AJOVY® injection
Presentation highlights include data for.
Designations for Daiichi Sankyo and AstraZeneca s ENHERTU include patients with HER2 expressing metastatic solid tumors and HER2 positive metastatic colorectal cancer
ENHERTU has now been granted.
Mortality rates remain substantially elevated after successful treatment of hepatitis C infection in the era of interferon-free antiviral therapy, a study of over 20,000 patients has found.